Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Clinical Investigation|December 21, 2004
Fabry disease: overall effects of agalsidase alfa treatmentM Beck, R Ricci, U Widmer, et al.
Folia Biologica|November 30, 2011
Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosisA Král, T Kovárník, L Králík, et al.
Scientific Reports|July 22, 2017
Corrigendum: Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesiclesJ Fafián-Labora, I Lesende-Rodriguez, P Fernández-Pernas, et al.
Clinical Genetics|July 22, 2014
A mutation in the Z-line Cypher/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathyJ M Lopez-Ayala, M Ortiz-Genga, I Gomez-Milanes, et al.
Casopis Lekaru Ceskych|April 28, 2006
[Pulmonary endarterectomy--the surgical treatment of chronic thromboembolic pulmonary hypertension]J Lindner, P Jansa, J Kunstýr, et al.
The Journal of Cardiovascular Surgery|May 18, 2011
A review of a newly established ECMO program in a university affiliated cardiac centerJ Belohlávek, V Rohn, J Tosovsky, et al.
Revista Clinica Espanola|September 5, 2018
Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa Registry) in Spain: Objectives, methods, and preliminary resultsA Riera-Mestre, J M Mora Luján, R Sanchez Martínez, et al.
International Journal of Cardiology|December 3, 2014
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significanceB E Smid, L van der Tol, F Cecchi, et al.
JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 21